Skip to content

Comparison of cefixime and azithromycin in pediatric dysentery

Comparison of cefixime and azithromycin in pediatric dysentery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014091013366N4
Enrollment
116
Registered
2014-11-08
Start date
2013-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysentery. Other gastroenteritis and colitis of infectious and unspecified origin

Interventions

Intervention 1: The first group will receive azithromycin for five days
the first day 12 mg / kg and for the next four days 6 mg / kg . Intervention 2: Group II will receive drug cefixime 8 mg / kg daily.
Treatment - Drugs
The first group will receive azithromycin for five days
the first day 12 mg / kg and for the next four days 6 mg / kg .
Group II will receive drug cefixime 8 mg / kg daily.

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Months to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Children 6 months to 12 years referred to Amir Kabir hospital pediatric clinic complaining of dysentery. Exclusion criteria: malabsorption; previous experience prolonged diarrhea; intestinal polyps; malnutrition; history of immunodeficiency disease of the small intestine combinations of probiotics; inflammatory bowel disease; a history of antibiotic use in the past month in the course of other diseases; lack of parental consent to continue working.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Stool. Timepoint: On days 3, 7 and 14. Method of measurement: Stool - a stool culture.

Secondary

MeasureTime frame
Antibiogram. Timepoint: On days 3, 7 and 14. Method of measurement: Experiment.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026